AstraZeneca PLC Ordinary Shares (AZN)
EBITDA Margin
33.72%
TTM · Period ending:
AZN EBITDA Margin
Latest reported33.72%period ending
Latest reported33.72%period ending
AZN TTM EBITDA Margin (17.34% → 33.72%)
TTM ebitda margin
High-resolution chart · PNG
AZN ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 33.7233% | |
| 33.8964% | |
| 33.7913% | |
| 31.0114% | |
| 29.9127% | |
| 29.2187% | |
| 28.6613% | |
| 30.0609% | |
| 29.7498% | |
| 30.0204% | |
| 30.4599% | |
| 30.8912% | |
| 29.6021% | |
| 25.7492% | |
| 21.0986% | |
| 18.9928% | |
| 16.1293% | |
| 16.9475% | |
| 20.1539% | |
| 24.1468% | |
| 29.7345% | |
| 32.4004% | |
| 31.3221% | |
| 32.0436% | |
| 30.3125% | |
| 27.8013% | |
| 27.5262% | |
| 29.7634% | |
| 31.4031% | |
| 33.4196% | |
| 32.1956% | |
| 28.4895% | |
| 28.6053% | |
| 29.1213% | |
| 29.5126% | |
| 36.2457% | |
| 36.3201% | |
| 32.4735% | |
| 31.632% | |
| 24.9076% | |
| 25.0935% | |
| 27.4126% | |
| 28.169% | |
| 23.5555% | |
| 21.6246% | |
| 21.8873% | |
| 20.706% | |
| 25.5408% | |
| 28.5454% | |
| 30.408% | |
| 32.4686% | |
| 35.0491% | |
| 37.4967% | |
| 37.8022% | |
| 38.6301% | |
| 38.2594% | |
| 42.995% | |
| 44.4101% | |
| 47.3252% | |
| 49.1208% | |
| 44.0894% | |
| 44.3626% | |
| 44.3235% | |
| 42.0544% | |
| 43.6296% | |
| 43.3742% | |
| 42.9582% | |
| 40.6964% | |
| 39.6465% | |
| 38.6024% | |
| 37.2267% | |
| 35.9744% | |
| 35.1404% | |
| 34.2914% | |
| 33.6615% | |
| 34.9718% | |
| 35.2359% | |
| 36.2789% | |
| 35.3579% | |
| 35.5254% | |
| 35.6069% | |
| 33.6491% | |
| 32.6889% | |
| 13.1228% | |
| 9.2593% | |
| 6.7662% | |
| 4.6672% | |
| 26.2023% | |
| 27.4985% | |
| 27.2125% | |
| 28.654% | |
| 27.8307% | |
| 26.1% | |
| 27.5535% | |
| 27.9262% | |
| 30.2838% | |
| 31.0394% | |
| 30.7164% | |
| 30.2565% | |
| 26.8589% |